Health Care The Watchlist BioVaxys Technology (CSE:BIOV) retains Maxim Group as financial advisor and investment banker This is sponsored content, please see full disclaimer here. Trevor Abes1 min18 April 2023 13:57 (EDT)
Health Care Market News BioVaxys Technology (CSE:BIOV) retains Maxim Group as financial advisor and investment banker BioVaxys (BIOV) retains New York City-based Maxim Group as its financial advisor and investment banker Maxim will... Trevor Abes1 min18 April 2023 09:01 (EDT)
Health Care Socials The Watchlist BioVaxys (CSE:BIOV) acquires TAETSoftware, completes financing BioVaxys (BIOV) has acquired TAETSoftware, a Vancouver-based clinical studies management company TAETSoftware is developing a software application... Trevor Abes2 mins16 March 2023 13:43 (EDT)
Health Care Socials The Watchlist BioVaxys (CSE:BIOV) and Procare Health execute U.S. distribution agreement BioVaxys (BIOV) and Procare Health Iberia have finalized a U.S. distribution agreementThe agreement covers Papilocare gel and... Trevor Abes2 mins20 December 2022 14:00 (EDT)
Health Care BioVaxys Technology Corp. (CSE:BIOV) closes private placement BioVaxys (BIOV) has completed a non-brokered private placement for gross proceeds of $405,000The company issued 4,050,000... John Ballem1 min10 November 2022 08:45 (EDT)
Health Care Sponsored The Watchlist BioVaxys (CSE:BIOV) signs binding term sheet for distribution of Papilocare in the U.S. BioVaxys Technology Corp. (BIOV) has signed a binding term sheet with Procare Health Iberia, S.L. of Barcelona,... John Ballem2 mins06 October 2022 13:15 (EDT)
Health Care Sponsored The Watchlist BioVaxys (CSE:BIOV) expands vaccines intellectual property portfolio BioVaxys Technology Corp. (BIOV) has broadened patent coverage for its viral vaccine platformBioVaxys filed an international... John Ballem1 min28 September 2022 12:45 (EDT)
Health Care The Market Online Deal Room BioVaxys Technology Corp. (CSE:BIOV) closes firs tranche of non-brokered private placement BioVaxys Technology (BIOV) has closed the first tranche of a non-brokered private placement for gross proceeds... John Ballem1 min26 August 2022 08:45 (EDT)
Health Care BioVaxys (CSE:BIOV) reports progress on a universal SARS vaccine BioVaxys Technology Corp. (BIOV) and Ohio State University have made progress on creating a universal vaccine... Caroline Egan2 mins03 June 2022 15:45 (EDT)
Health Care Sponsored The Watchlist BioVaxys (CSE:BIOV) expands cancer vaccine platform BioVaxys Technology Corp. (BIOV) has expanded its cancer vaccine platform with BVX-0922BioVaxys plans to advance an... John Ballem1 min30 March 2022 13:45 (EDT)
